Begin main content

Lisdexamfetamine dimesylate

Last Updated: July 10, 2009
Result type: Reports
Project Number: S0171
Product Line: Common Drug Review

Generic Name: Lisdexamfetamine dimesylate

Brand Name: Vyvanse

Manufacturer: Shire Canada Inc.

Indications: Attention deficit hyperactivity disorder

Submission Type: New

Project Status: Complete

Date Recommendation Issued: December 18, 2009

Recommendation Type: Do not list